therapeutic 1,417 words KG: ent-gene-5b0668d7 2026-03-31
kind:therapeuticsection:therapeuticsstate:publishedtopic:alzheimerstopic:parkinsonstopic:alstopic:huntingtons
Contents

RAGE (Receptor for Advanced Glycation End Products) Modulator Therapy

🔬 Protein Info
Gene Symbolent-gene-5b0668d7
ApproachMechanism
RAGE domain blockersBind extracellular domain, block ligand interaction
RAGE antagonistsInhibit intracellular signaling
Anti-RAGE antibodiesNeutralize RAGE or its ligands
Decoy receptorsSoluble RAGE-Fc fusion proteins
HMGB1 antagonistsBlock RAGE ligand activation
S100B neutralizationBlock astrocyte-derived activation
AgentMechanism
Anti-HMGB1 antibodiesNeutralize HMGB1 alarmin
Box A peptideHMGB1 antagonist
GlycyrrhizinHMGB1 inhibitor
BiomarkerSource
sRAGEPlasma, CSF
HMGB1CSF, plasma
RAGE expressionPET ligands (in development)
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Conversion Therapy
Score: 0.44
Microbial Inflammasome Priming Prevention
Score: 0.58

Related Analyses (22)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

Related Experiments (9)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40

See Also (4)

LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 3 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 3 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 3 hypotheses
Adipose-Derived Mesenchymal Stem Cell Therapy for Early
clinical · Pages share 3 hypotheses

Knowledge Graph (2 edges)

ent-gene-5b0668d7 data_in benchmark_ot_ad_answer_key:RAGE
benchmark_ot_ad_answer_key:RAGE data_in ent-gene-5b0668d7